Healthcare Blogs

  Market Insights The global cell therapy market is due to grow at a CAGR of 9.3% during the forecast period of 2022 to 2030 according to Market Research Future's latest report on the subject. Cell therapy market  has emerged as a transformative field in biotechnology due to its use for the targeting of various diseases at a cellular level. The above-average growth expected by this market will primarily be due to the rapidly advancing healthcare sector and growing breakthrough research and development activities. Cell therapy is finding a growing number of applications in healthcare and is often used in combination with gene therapy. Presently, applications of cell therapy include urinary problems, cancers, autoimmune disease, and infectious disease among several others. The growing prevalence of chronic and lifestyle diseases is an important driver for the cell therapy market.  cell therapy processing  is also being developed in regenerative medicine which carries massive potentia

  Market Highlights The global  drug discovery informatics market  held a market value of USD 6.3 billion in 2030 and is projected to grow at a CAGR of 10.8% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics. Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases. For instance, according to t

  Market Highlights The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes. The Global  Soft Tissue Repair Market  is expected to grow at an approximate CAGR of 7.4% during the forecast period, 2022–2030. Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market. However, the high cost of  advanced soft tissue release  equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period. Regional Analysis In 2017, it was estimated that Europe stood second in the global soft ti

  Market Highlights The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centers and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals may hamper the market growth during the assessment period. The global  medical imaging software market  held a market value of USD 2,899.61 million in 2022 and is projected to grow at a CAGR of

       Healthcare Predictive Analytics Market Overview The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes. Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions. It is estimated that the global  healthcare predictive analytics market  is expected to register a CAGR ~29.50% during the forecast period of 2022–2030. Healthcare Predictive Analytics Market Regional Analysis On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. He

  Market Highlights Porcine vaccines aid the swine or hogs suffering from epidemic swine diseases. It also helps in improving overall efficiency in protecting swine from deadly viruses, bacteria and increases the production level of high-quality meat and gelatine. The global  porcine vaccines market  held a market value of USD 2,429.76 million in 2020 and is projected to grow at a CAGR of 7.20% over the forecast period. The increasing prevalence of swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. are anticipated to drive the market growth during the forecast period.  Additionally, rising number of biotechnology companies, research institutions engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and increasing demand for  porcine meal  and gelatine are likely to contribute to the market growth. For instance, by the world

  Market Highlights The Global blood pressure transducers market is expected to grow at an approximate CAGR of 5.2% during forecast period. Rising occurrence of obesity is the key factor driving the blood pressure transducers market. According to the 2015 data suggested by the Australian Institute of Health and Welfare, nearly two-thirds (63%) of Australian adults were overweight or obese. Various other factors such as sedentary lifestyle, lack of physical activities, technological advancements, presence of a large target patient population, rising patient awareness regarding the benefits of  blood pressure transducers , availability of fiber optic blood transducers, and growing demand for disposable blood pressure transducers are also expected to propel the growth of the market. However, stringent government regulations, high cost associated with technological development, and lack of trained professionals can hamper the market growth over the forecast period. Regional Analysis The Am

  Market Highlights: Medical case management is a collective process that allows recommended treatment plans to ensure suitable medical care is offered to disabled, ill or injured individuals. These services are provided under the direction of, or by referral from a clinical provider and encompass client-centered services that implement the clinical treatment plan, including linking clients with healthcare, psychosocial, and other services. Case management helps in controlling costs and improving the quality of health and social service delivery. Few of the major market growth factors are the presence of government initiatives & regulations to promote patient-centric care, rising initiatives to shift the burden of risk from healthcare payers to providers, growing need to curtail healthcare-associated costs, increasing need for improved quality of care, and booming healthcare IT sector. The Global  Medical Case Management Market  held a market value of USD 4,379.3 million in 2020 an

  Market Highlights: The Global Fabry Disease Market is expected to grow at a CAGR of 7.8% during the forecast period. Technological advancements, strong pipeline, advancements in healthcare facilities, and favourable funding policies are expected to drive the market growth over the forecast period. Owing to the increasing awareness about  Fabry disease market  new and existing market players are coming up with better treatment approaches. For instance, in 2018, 2018, Amicus Therapeutics launched Galafold capsules 123mg for the treatment of patients aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation. However, diverse range of symptoms, and related complications can restrain the market growth over the assessment period. Segmentation: The Global Fabry Disease Market has been segmented into type, diagnosis & treatment and end user. The market, by diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis

  Market Highlights: Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of

  Market Highlights Cell Viability Assays is a type of technique that is used for determining viable cells in the culture. Market Research Future (MRFR) has published a research report about the global cell viability assays market that prognosticates prosperity for this market at 9.2% CAGR (Compound Annual Growth Rate) between 2020 and 2027. The imperative factor driving the global cell viability assays market growth is the growing prevalence of chronic ailments and infectious diseases. Other important factors aiding the market growth include growing availability of funds for cell-based research, increasing focus on developing cell-based therapeutics, and the rising need of cell-based assays in research and development (R&D) activities. The global  cell viability assays market  segmentation has segmented the market into applications, cell type, end user, products, and lastly, region. The application-based segmentation segments this market into clinical & diagnostic applications

  Market Highlights Healthcare claims management process comprises of various tasks such as organization, billing, filling, updating, and processing of medical claims related to the diagnosis, treatment, and medication of patients. The healthcare claims management market is driven by factors such as improved focus on quality healthcare services and adoption of cloud-based technology related services. However, integration of claims management solutions, data breaches, loss of confidentiality, and lack of skilled IT professionals in healthcare are some of the factors restraining the growth of this market.  The global  healthcare claims management market  is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, IBM’s IPD Ultera for Disability Claims provides an integrated “disability claims management workbench”, specific to disability claims processing and

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device market . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Segmentation The global cardiac monitoring and  cardiac rhythm manageme

  Market Highlights The increasing prevalence of chronic kidney diseases, increase in alcohol consumption, change to sedentary lifestyle, growing prevalence of diabetes, rising obesity and increasing prevalence of cardiovascular diseases are the key factors for the market to grow. However, factors such as high cost of diagnostic procedures, infections, and huge initial investments are expected to restrict the market growth during the forecast period. The global  kidney function test market  is expected to reach an approximate CAGR of 5.7% during the forecast period. Segmentation The global kidney function test market is segmented on the basis of tests, product, and end-user. The kidney function test market, by tests categorized into blood tests, imaging tests, urine tests balloons and  kidney stents  biopsy. Blood tests category includes serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urin